The South Korea healthcare cold chain logistics market is expected to exhibit a growth rate (CAGR) of 4.3% during 2023-2028.
Healthcare cold chain logistics help maintain the integrity of temperature-sensitive medical products like vaccines during transportation. They rely on a digital system for monitoring the cold chain and logistics at service delivery points and generating actionable data, which is provided to a designated person at each level of the cold chain. Nowadays, healthcare service providers require real-time monitoring and reporting for storing and transporting biological products. As a result, the demand for advanced healthcare cold chain logistics systems is rising in South Korea.
South Korea Healthcare Cold Chain Logistics Market Trends:
The rising need for vaccines and biopharmaceuticals due to the increasing prevalence of infectious and chronic disorders represents one of the key factors catalyzing the demand for healthcare cold chain logistics in South Korea. Apart from this, the integration of augmented reality (AR), blockchain, and the internet of things (IoT) with cold chain monitoring systems to offer predictive alerts of warehouse management, transportation, and delivery is driving the market in the country. Furthermore, the escalating demand for transporting highly sophisticated clinical trial specimens and biologics is contributing to the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the South Korea healthcare cold chain logistics market report, along with forecasts at the country and regional level from 2023-2028. Our report has categorized the market based on product and segment.
Breakup by Product:
Breakup by Segment:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Base Year of the Analysis
Product, Segment, Region
East, West, Southwest, Southeast
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
We expect the South Korea healthcare cold chain logistics to exhibit a CAGR of 4.3% during 2023-2028.
The rising demand for delivering clinical trial specimens and biologics is primarily driving the South Korea healthcare cold chain logistics market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of healthcare cold chain logistics across the nation, to maintain the integrity of temperature-sensitive medical products, including vaccines, during their transportation.
Based on the product, the South Korea healthcare cold chain logistics has been divided into biopharmaceuticals, vaccines, and clinical trials. Among these, vaccines currently exhibit a clear dominance in the market.
Based on the segment, the South Korea healthcare cold chain logistics can be segmented into transportation, packaging, and instrumentation. Currently, transportation holds the majority of the total market share.
On a regional level, the market has been classified into East, West, Southwest, and Southeast.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.